SUNNYVALE, Calif. April 6, 2023 (PRWEB) April 06, 2023 CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer screening blood
If colon cancer blood tests eventually win FDA approval and Medicare reimbursement, their use could become more widespread. But first this approach needs to match up against the current standard.
SUNNYVALE, Calif. (PRWEB) February 21, 2023 CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer screening blood test, today
CellMax Life and Sebela Pharmaceuticals Enter Strategic Development and Commercialization Partnership for FirstSight™ Blood Test for Detection of Colorectal Cancer and Pre-Cancer prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.